Page last updated: 2024-11-02

pd 98059 and Liver Steatosis

pd 98059 has been researched along with Liver Steatosis in 2 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Zheng, C1
Zheng, Y1
Chen, X1
Zhong, X1
Zheng, X1
Yang, S1
Zheng, Z1
Kosone, T1
Takagi, H1
Horiguchi, N1
Ariyama, Y1
Otsuka, T1
Sohara, N1
Kakizaki, S1
Sato, K1
Mori, M1

Other Studies

2 other studies available for pd 98059 and Liver Steatosis

ArticleYear
α-NETA down-regulates CMKLR1 mRNA expression in ileum and prevents body weight gains collaborating with ERK inhibitor PD98059 in turn to alleviate hepatic steatosis in HFD-induced obese mice but no impact on ileal mucosal integrity and steatohepatitis pro
    BMC endocrine disorders, 2023, Jan-10, Volume: 23, Issue:1

    Topics: Animals; Body Weight; Diet, High-Fat; Fatty Liver; Ileum; Intestinal Mucosa; Liver; Male; Mice; Mice

2023
HGF ameliorates a high-fat diet-induced fatty liver.
    American journal of physiology. Gastrointestinal and liver physiology, 2007, Volume: 293, Issue:1

    Topics: Animals; Apolipoproteins B; Blood Glucose; Carrier Proteins; Dietary Fats; Fatty Liver; Flavonoids;

2007